Stay updated with breaking news from Simulated Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cancer Research Horizons, the innovation engine at the core of the world's largest private funder of cancer research, Cancer Research UK, is partnering with Turbine,* a tech-enabled biotech leveraging
Turbine – a London-based company with a cell simulation platform that can predict the effectiveness of cancer treatments – has completed a €20m Series A financing round. Mercia and MSD Global Health Innovation (GHI) Fund (MSD is the trade name of Merck & Co., Inc., Rahway NJ, USA) co-led the financing, joined by ...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
€20m financing will focus on treatment pathways, new partnerships and team expansion - News - PharmaTimes
Merck & Co's strategic investment fund was revealed as a co-lead investor.